Soo Ngoi - Concepedia

Author

Soo Ngoi

UConn Health

Also Known As

Soo M Ngoi, Soo M. Ngoi, Soo Mun Ngoi, Soo Ngoi

Publications

485

Citations

H-Index

Concepts

All Affiliations

UConn Health The Ohio State University Medical University of South Carolina MUSC Hollings Cancer Center

About

Soo Ngoi is an author at UConn Health specializing in medicine, immunology, and immunotherapy.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	2	2	83
2	Immunology	2	2	83
3	Allergy	1	1	13
4	Cell Biology	1	1	70
5	Microbiology	1	1	13

Soo Ngoi

Publications

416

Citations

H-Index

Page 1

	Year	Citations
Effects of the microalgae Chlamydomonas on gastrointestinal health Francis J. Fields, Franck Lejzerowicz, Dave Schroeder, Journal of Functional Foods	2019	104
Targeting Poly(I:C) to the TLR3-Independent Pathway Boosts Effector CD8 T Cell Differentiation through IFN-α/β Soo Ngoi, Michaël G. Tovey, Anthony T. Vella The Journal of Immunology	2008	73
Type 2 dendritic cells mediate control of cytotoxic T cell resistant tumors Stephen Iwanowycz, Soo Ngoi, Yingqi Li, JCI Insight ImmunologyImmunoeditingImmunotherapeuticsImmunotherapyTumor Biology	2021	70
Costimulation Endows Immunotherapeutic CD8 T Cells with IL-36 Responsiveness during Aerobic Glycolysis Naomi Tsurutani, Payal Mittal, Marie‐Clare St. Rose, The Journal of Immunology	2015	50
TLR4 Hyperresponsiveness via Cell Surface Expression of Heat Shock Protein gp96 Potentiates Suppressive Function of Regulatory T Cells Jie Dai, Bei Liu, Soo Ngoi, The Journal of Immunology	2007	49
Presensitizing with a Toll-like receptor 3 ligand impairs CD8 T-cell effector differentiation and IL-33 responsiveness Soo Ngoi, Marie‐Clare St. Rose, Antoine Ménoret, Proceedings of the National Academy of Sciences	2012	33
Migrating Type 2 Dendritic Cells Prime Mucosal Th17 Cells Specific to Small Intestinal Commensal Bacteria Soo Ngoi, Yi Yang, Stephen Iwanowycz, The Journal of Immunology	2022	14
The role of microbial byproducts in protection against immunological disorders and the hygiene hypothesis. Soo Ngoi, Francisco Sylvester, Anthony T. Vella PubMed DysbiosisTlr LigandsImmunological DisordersImmunologyInnate Immune System	2011	13
Evaluating the efficacy of enzalutamide and the development of resistance in a preclinical mouse model of type-I endometrial carcinoma Christopher S. Koivisto, Melodie Parrish, Santosh Bonala, Neoplasia	2020	10

Page 1